14 October 2022 in Science
We engineered an ultrasensitive reporter of p16 INK4a , a biomarker of cellular senescence. Our reporter detected p16 INK4a -expressing fibroblasts with certain senescent characteristics that appeared shortly after birth in the basement membrane adjacent to epithelial stem cells in the lung. Furthermore, these p16 INK4a+ fibroblasts had enhanced capacity to sense tissue inflammation and respond through their increased secretory capacity to promote epithelial regeneration. In addition, p16 INK4a expression was required in fibroblasts to enhance epithelial regeneration. This study highlights a role for p16 INK4a+ fibroblasts as tissue-resident sentinels in the stem cell niche that monitor barrier integrity and rapidly respond to inflammation to promote tissue regeneration.
7 March 2024 in Journal of Clinical Investigation
The appearance of senescent cells in age-related diseases has spurred the search for compounds that can target senescent cells in tissues, termed senolytics. However, a major caveat with current senolytic screens is the use of cell lines as targets where senescence is induced in vitro, which does not necessarily reflect the identity and function of pathogenic senescent cells in vivo. Here, we developed a new pipeline leveraging a fluorescent murine reporter that allows for isolation and quantification of
p16
Ink4a+
cells in diseased tissues. By high-throughput screening in vitro, precision-cut lung slice (PCLS) screening ex vivo, and phenotypic screening in vivo, we identified a HSP90 inhibitor, XL888, as a potent senolytic in tissue fibrosis. XL888 treatment eliminated pathogenic
p16
Ink4a+
fibroblasts in a murine model of lung fibrosis and reduced fibrotic burden. Finally, XL888 preferentially targeted
p16
INK4a-hi
human lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis (IPF), and reduced
p16
INK4a+
fibroblasts from IPF PCLS ex vivo. This study provides proof of concept for a platform where
p16
INK4a+
cells are directly isolated from diseased tissues to identify compounds with in vivo and ex vivo efficacy in mice and humans, respectively, and provides a senolytic screening platform for other age-related diseases.
7 July 2020 in PLOS Pathogens
Listeria monocytogenes is a facultative intracellular bacterial pathogen that escapes from phagosomes and induces a robust adaptive immune response in mice, while mutants unable to escape phagosomes fail to induce a robust adaptive immune response and suppress the immunity to wildtype bacteria when co-administered. The capacity to suppress immunity can be reversed by blocking IL-10. In this study, we sought to understand the host receptors that lead to secretion of IL-10 in response to phagosome-confined L. monocytogenes (Δhly), with the ultimate goal of generating strains that fail to induce IL-10. We conducted a transposon screen to identify Δhly L. monocytogenes mutants that induced significantly more or less IL-10 secretion in bone marrow-derived macrophages (BMMs). A transposon insertion in lgt, which encodes phosphatidylglycerol-prolipoprotein diacylglyceryl transferase and is essential for the formation of lipoproteins, induced significantly reduced IL-10 secretion. Mutants with transposon insertions in pgdA and oatA, which encode peptidoglycan N-acetylglucosamine deacetylase and O-acetyltransferase, are sensitive to lysozyme and induced enhanced IL-10 secretion. A ΔhlyΔpgdAΔoatA strain was killed in BMMs and induced enhanced IL-10 secretion that was dependent on Unc93b1, a trafficking molecule required for signaling of nucleic acid-sensing TLRs. These data revealed that nucleic acids released by bacteriolysis triggered endosomal TLR-mediated IL-10 secretion. Secretion of IL-10 in response to infection with the parental strain was mostly TLR2-dependent, while IL-10 secretion in response to lysozyme-sensitive strains was dependent on TLR2 and Unc93b1. In mice, the IL-10 response to vacuole-confined L. monocytogenes was also dependent on TLR2 and Unc93b1. Co-administration of Δhly and ΔactA resulted in suppressed immunity in WT mice, but not in mice with mutations in Unc93b1. These data revealed that secretion of IL-10 in response to L. monocytogenes infection in vitro is mostly TLR2-dependent and immune suppression by phagosome-confined bacteria in vivo is mostly dependent on endosomal TLRs. Listeria monocytogenes is a Gram-positive bacterial pathogen that has shown promise as a vaccine-delivery vector because of its ability to stimulate a robust T-cell response. The efficacy of a vaccine is in part tied to how well it avoids inducing the immunosuppressive cytokine IL-10. In this work, we investigated the bacterial and host factors that contribute to secretion of IL-10 and immunosuppression following infection with a strain of L. monocytogenes that cannot escape from host cell vacuoles. We identified TLR2 and Unc93b1-dependent nucleic-acid-sensing Toll-like receptors as the primary host mediators of IL-10 secretion and immunosuppression. Unc93b1-dependent TLRs likely recognize nucleic acids released upon bacterial lysis in phagosomes. Strategies that reduce lytic death of bacteria and subsequent recognition of nucleic acids by endosomal TLRs could be used to improve bacteria-based vaccines.
15 June 2026 in Journal of Virology
Human cytomegalovirus (HCMV) is a major cause of congenital disease and a significant threat to immunocompromised individuals, particularly transplant recipients and neonates. Over the past five decades, numerous monoclonal antibodies (mAbs) targeting various HCMV antigens have been isolated. Here, we present a comprehensive review of HCMV-specific mAbs isolated from the 1980s to the present, detailing their target antigens, epitopes, neutralizing activity, and potential clinical applications. This review integrates historical discoveries with recent structural and functional studies, highlighting trends that may inform the development of anti-HCMV therapeutics and prophylactics.
22 September 2026 in Journal of Virology
Monoclonal antibody (mAb) cocktails are increasingly used as antiviral therapeutics, but methods for evaluating mAb combination effects remain poorly standardized. To characterize interactions of recently isolated neutralizing mAbs targeting human cytomegalovirus glycoprotein B, we compared three screening approaches: checkerboard neutralization assays; DiaMOND, a high-throughput small-molecule interaction screening tool modified for mAb combinations; and EMERALD, a modified variable-ratio framework. As the most systematic approach, the checkerboard assay served as the baseline for subsequent comparisons. Most mAb combinations in checkerboard assays were classified as additive or antagonistic according to Loewe additivity-based analyses, regardless of whether the mAbs were competing or non-competing. Apparent synergy was observed primarily at saturating antibody concentrations. When adapted for mAb combinations, the DiaMOND framework produced interaction profiles that differed from checkerboard results under both concentration-based and dose-matched conditions. In contrast, EMERALD captured concentration-dependent interactions across variable mAb ratios and revealed asymmetric behavior, depending on which mAb was held constant. Together, these findings demonstrate that classifications of mAb interactions depend strongly on assay design, concentration range, and analytical framework. They further suggest that robust mAb synergy may be less common than often reported and highlight the need to evaluate antiviral mAb combinations across multiple experimental formats. IMPORTANCE: Monoclonal antibody cocktails are gaining foothold as an important strategy for the prevention and treatment of viral infections. Synergistic antibody combinations are often reported, but whether they represent true synergy is unclear because classifications of interactions depend on the experimental design and analytical methods. Moreover, there is no broadly accepted methodology for evaluating interactions among antibody combinations. As a result, it remains unclear whether common approaches for screening antibody combinations accurately capture biologically relevant interactions. Here, we compared four approaches for evaluating antibody combinations to help define best experimental and analytical practices for studying antiviral antibody interactions. Our findings demonstrate that antibody interactions are highly dependent on assay design, choice of antibody concentrations, and timing of antibody exposure, suggesting that synergy and antagonism are not fixed properties of antibody pairs. These findings may be broadly applicable to studies of antiviral antibody combinations across diverse viral systems.